Morgan Stanley’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$31.4M Sell
1,500,528
-325,767
-18% -$7.34M ﹤0.01% 2536
2025
Q4
$42M Buy
1,826,295
+916,112
+101% +$30.1M ﹤0.01% 2252
2025
Q3
$27.4M Buy
910,183
+271,304
+42% +$8.14M ﹤0.01% 2578
2025
Q2
$23.2M Buy
638,879
+12,479
+2% +$450K ﹤0.01% 2654
2025
Q1
$22.7M Buy
626,400
+28,211
+5% +$1.17M ﹤0.01% 2565
2024
Q4
$25.2M Buy
598,189
+130,353
+28% +$6.47M ﹤0.01% 2538
2024
Q3
$26M Sell
467,836
-30,133
-6% -$1.53M ﹤0.01% 2517
2024
Q2
$20.5M Sell
497,969
-6,413
-1% -$274K ﹤0.01% 2639
2024
Q1
$23.5M Sell
504,382
-690,716
-58% -$32.6M ﹤0.01% 2518
2023
Q4
$57.1M Buy
1,195,098
+699,609
+141% +$27.1M ﹤0.01% 2295
2023
Q3
$17.7M Sell
495,489
-21,686
-4% -$859K ﹤0.01% 2596
2023
Q2
$23.9M Buy
517,175
+158,765
+44% +$7.36M ﹤0.01% 2296
2023
Q1
$14.4M Buy
358,410
+50,063
+16% +$2.15M ﹤0.01% 2787
2022
Q4
$14.3M Sell
308,347
-91,766
-23% -$3.61M ﹤0.01% 2692
2022
Q3
$16.6M Buy
400,113
+70,464
+21% +$3.62M ﹤0.01% 2407
2022
Q2
$19.7M Buy
329,649
+84,910
+35% +$5.22M ﹤0.01% 2309
2022
Q1
$17.8M Buy
244,739
+52,735
+27% +$3.67M ﹤0.01% 2244
2021
Q4
$16.1M Sell
192,004
-37,065
-16% -$3.02M ﹤0.01% 2397
2021
Q3
$20.7M Sell
229,069
-161,029
-41% -$14.6M ﹤0.01% 2052
2021
Q2
$37.2M Buy
390,098
+152,916
+64% +$15.9M ﹤0.01% 1552
2021
Q1
$27M Sell
237,182
-14,146
-6% -$1.93M ﹤0.01% 1648
2020
Q4
$34.8M Buy
251,328
+129,855
+107% +$15.4M 0.01% 1366
2020
Q3
$9.98M Buy
121,473
+27,170
+29% +$2.25M ﹤0.01% 2032
2020
Q2
$7.38M Buy
94,303
+13,688
+17% +$906K ﹤0.01% 2265
2020
Q1
$3.58M Sell
80,615
-75,895
-48% -$3.94M ﹤0.01% 2777
2019
Q4
$6.68M Buy
156,510
+16,850
+12% +$695K ﹤0.01% 2868
2019
Q3
$5.97M Buy
139,660
+55,492
+66% +$3.01M ﹤0.01% 2669
2019
Q2
$5.34M Buy
84,168
+61,549
+272% +$3.92M ﹤0.01% 2857
2019
Q1
$1.57M Sell
22,619
-124,619
-85% -$7.12M ﹤0.01% 3786
2018
Q4
$6.4M Sell
147,238
-3,950
-3% -$216K ﹤0.01% 2596
2018
Q3
$11.5M Sell
151,188
-34,247
-18% -$2.79M ﹤0.01% 2266
2018
Q2
$14.3M Buy
185,435
+68,812
+59% +$4.44M ﹤0.01% 1985
2018
Q1
$5.95M Buy
116,623
+21,984
+23% +$1.11M ﹤0.01% 2847
2017
Q4
$4.39M Buy
94,639
+11,890
+14% +$583K ﹤0.01% 3251
2017
Q3
$4.41M Buy
82,749
+16,128
+24% +$956K ﹤0.01% 3094
2017
Q2
$4.14M Sell
66,621
-9,487
-12% -$572K ﹤0.01% 3048
2017
Q1
$5.16M Sell
76,108
-59,952
-44% -$4.57M ﹤0.01% 2835
2016
Q4
$9.57M Buy
136,060
+86,127
+172% +$6.11M ﹤0.01% 2300
2016
Q3
$3.54M Buy
49,933
+17,272
+53% +$1.1M ﹤0.01% 3004
2016
Q2
$1.6M Buy
32,661
+3,469
+12% +$224K ﹤0.01% 3605
2016
Q1
$1.85M Sell
29,192
-1,489
-5% -$97.4K ﹤0.01% 3413
2015
Q4
$3.44M Sell
30,681
-6,794
-18% -$679K ﹤0.01% 3029
2015
Q3
$3.61M Sell
37,475
-16,289
-30% -$1.87M ﹤0.01% 2938
2015
Q2
$5.5M Sell
53,764
-17,228
-24% -$1.34M ﹤0.01% 2704
2015
Q1
$4.41M Buy
70,992
+3,831
+6% +$213K ﹤0.01% 2869
2014
Q4
$2.95M Sell
67,161
-2,219
-3% -$102K ﹤0.01% 3217
2014
Q3
$3.93M Buy
69,380
+25,226
+57% +$1.27M ﹤0.01% 2842
2014
Q2
$1.98M Sell
44,154
-37,951
-46% -$1.56M ﹤0.01% 3488
2014
Q1
$4.01M Buy
+82,105
New +$4.23M ﹤0.01% 2781

Other funds holding RARE